healthy adult
Conditions
Interventions
The test product will be a No. 2 hard capsule (made of hydroxypropyl methylcellulose) containing 100 mg of Macaranga tanarius fruit extract. The administration period will generally be four weeks, an
Sponsors
Southen Knights' Laboratory Co., Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Basically, healthy men and women aged 20 to 65
Exclusion criteria
Exclusion criteria: Participants who meet any of the following criteria will be excluded. 1) Participants currently receiving treatment for or have a history of malignant tumors, heart failure, or myocardial infarction. 2) Participants with a pacemaker or implantable cardioverter-defibrillator. 3) Participants currently receiving treatment for the following chronic diseases: arrhythmia, liver damage, chronic kidney disease, cerebrovascular disease, rheumatic disease, diabetes, dyslipidemia, hypertension, cardiovascular disease, and other chronic diseases. 4) Participants currently taking foods for specified health uses or foods with functional claims. 5) Participants currently taking or using medicines (including herbal medicines) or supplements. 6) Participants with allergies (to medicines or foods related to the test food). 7) Participants currently pregnant, breastfeeding, or intending to become pregnant during the study period. 8) Participants who have participated in other clinical trials within the 28 days prior to the consent acquisition date, or who plan to participate in such trials during the study period. 9) Participants deemed inappropriate for this study by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| General blood tests and blood biochemistry tests | — |
Countries
Japan
Contacts
Public ContactKimio Sugaya
Southen Knights' Laboratory Co., Ltd. Representative Director
Outcome results
None listed